Paper2500406
Folinic acid modulation of fluorouracil: tissue kinetics of bolus administration.
Spears CP and 2 others. Invest New Drugs, 1989. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Folinic acid modulation of fluorouracil: tissue kinetics of bolus administration. Papers, record 2500406. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2500406
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fluorouracil | Major topic |
| Leucovorin | Major topic |
| Aged | |
| Biotransformation | |
| Colonic Neoplasms | |
| Cytosol | |
| Drug Interactions | |
| Female | |
| Fluorodeoxyuridylate | |
| Humans | |
| Lacticaseibacillus casei | |
| Male | |
| Middle Aged | |
| Thymidylate Synthase |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CA 39629 | NCI NIH HHS | United States | R01CA039629 | PubMed and NIH |
Source NIH RePORTER
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6164559 | Selective enhancement of 5-fluorouridine uptake and action in rat hepatomas in vivo following pretreatment with D-galactosamine and 6-azauridine or N-(phosphonacetyl)-L-aspartate. | Eur J Cancer (1965) | 1980 | https://conductscience.org/library/papers/6164559 | PubMed |
| 2 | 2783153 | Deoxyuridylate effects on thymidylate synthase-5-fluorodeoxyuridylate-folate ternary complex formation. | Biochem Pharmacol | 1989 | https://conductscience.org/library/papers/2783153 | PubMed |
| 3 | 3167844 | Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil. | Cancer Res | 1988 | https://conductscience.org/library/papers/3167844 | PubMed |
| 4 | 5350077 | Influence of ribose donors on the action of 5-fluorouracil. | Cancer Res | 1969 | https://conductscience.org/library/papers/5350077 | PubMed |
| 5 | 7449757 | Activation and protection from 5-fluorodeoxyuridylate inactivation of mammalian thymidylate synthetase by pyridoxal 5'-phosphate. | Enzyme | 1980 | https://conductscience.org/library/papers/7449757 | PubMed |
| 6 | 21043247 | Effect of de novo purine synthesis inhibitors on 5-fluorouracil metabolism and cytotoxicity. | Biochem Pharmacol | 1981 | https://conductscience.org/library/papers/21043247 | PubMed |
| 7 | 4203910 | Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate. | Biochemistry | 1974 | https://conductscience.org/library/papers/4203910 | PubMed |
| 8 | 6688119 | Relationship of cellular folate cofactor pools to the activity of 5-fluorouracil. | Mol Pharmacol | 1983 | https://conductscience.org/library/papers/6688119 | PubMed |
| 9 | 125086 | Quenching of thymidylate synthetase fluorescence by substrate analogs. | Biochem Biophys Res Commun | 1975 | https://conductscience.org/library/papers/125086 | PubMed |
| 10 | 3487626 | High-dose continuous infusion folinic acid and bolus 5-fluorouracil in patients with advanced colorectal cancer: a phase II study. | J Clin Oncol | 1986 | https://conductscience.org/library/papers/3487626 | PubMed |
| 11 | 157805 | Assay of intracellular free and macromolecular-bound metabolites of 5-fluorodeoxyuridine and 5-fluorouracil. | Cancer Res | 1979 | https://conductscience.org/library/papers/157805 | PubMed |
| 12 | 6762925 | Is there a role for thymidine in cancer chemotherapy? | Cancer Treat Rev | 1982 | https://conductscience.org/library/papers/6762925 | PubMed |
| 13 | 7377545 | A centrifugal column assay for thymidylate synthetase using the active site titrant 5-fluoro-2'-deoxyuridylate. | Anal Biochem | 1980 | https://conductscience.org/library/papers/7377545 | PubMed |
| 14 | 6189380 | Fluorinated pyrimidines and their nucleosides. | Adv Enzymol Relat Areas Mol Biol | 1983 | https://conductscience.org/library/papers/6189380 | PubMed |
| 15 | 6973389 | Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil. | Cancer Res | 1981 | https://conductscience.org/library/papers/6973389 | PubMed |
| 16 | 3943080 | Effects of methotrexate on folates in Krebs ascites and L1210 murine leukemia cells. | Cancer Lett | 1986 | https://conductscience.org/library/papers/3943080 | PubMed |
| 17 | 147465 | Cytotoxicity of 5-fluoro-2'-deoxyuridine: requirement for reduced folate cofactors and antagonism by methotrexate. | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/147465 | PubMed |
| 18 | 6939434 | Biochemical factors affecting the tightness of 5-fluorodeoxyuridylate binding to human thymidylate synthetase. | Biochem Pharmacol | 1981 | https://conductscience.org/library/papers/6939434 | PubMed |
| 19 | 6982167 | The enhancement of 5-fluorouracil anti-metabolic activity by leucovorin, menadione and alpha-tocopherol. | Eur J Cancer Clin Oncol | 1982 | https://conductscience.org/library/papers/6982167 | PubMed |
| 20 | 472732 | Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: explanation for drug synergism. | Science | 1979 | https://conductscience.org/library/papers/472732 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36612253 | Increasing Dosage of Leucovorin Results in Pharmacokinetic and Gene Expression Differences When Administered as Two-Hour Infusion or Bolus Injection to Patients with Colon Cancer. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36612253 | PubMed |
| 33613849 | Folinic acid in colorectal cancer: esquire or fellow knight? Real-world results from a mono institutional, retrospective study. | Oncotarget | 2021 | https://conductscience.org/library/papers/33613849 | PubMed |
| 14735184 | Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study. | Br J Cancer | 2004 | https://conductscience.org/library/papers/14735184 | PubMed |
| 8027622 | Adjuvant intraperitoneal 5-fluorouracil and intravenous leucovorin after colorectal cancer surgery: a randomized phase II placebo-controlled study. | Int J Colorectal Dis | 1994 | https://conductscience.org/library/papers/8027622 | PubMed |
| 2793368 | Schedule-dependency of in vivo modulation of 5-fluorouracil by leucovorin and uridine in murine colon carcinoma. | Invest New Drugs | 1989 | https://conductscience.org/library/papers/2793368 | PubMed |
| 1764871 | Pharmacokinetic optimisation of anticancer therapy. | Clin Pharmacokinet | 1991 | https://conductscience.org/library/papers/1764871 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TYMS | 7298 | PubTator's text mining | https://conductscience.org/library/genes/7298 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2500406
GET https://conductscience.org/api/papers/v1/2500406/references?page=2